Evidence map›Paper›PMID 39162259›Full record

ArticleMicrobiology spectrum2024

Emergence of a novel sequence type carbapenem-resistant hypervirulent

Junnian Liu, Sue Yuan, Luhan Xuan, Yu Sun, Xinyu Zhang, Lu Qiao, Xuefei Du

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Junnian Liu *Clinical Laboratory, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.ORCID 0009-0006-4068-3143
Sue Yuan *Clinical Laboratory, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Luhan XuanClinical Laboratory, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Yu SunClinical Laboratory, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Xinyu ZhangClinical Laboratory, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Lu QiaoClinical Laboratory, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Xuefei DuClinical Laboratory, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant hypervirulent IMPORTANCE: ST11 and its variants, which often exhibit drug resistance, represent popular clones of carbapenem-resistant hypervirulent

Indexed as

Anti-Bacterial AgentsCarbapenemsKlebsiella InfectionsKlebsiella pneumoniaePlasmidsAnimalsBacterial Proteinsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeChinaDrug Resistance, Multiple, BacterialHumansMaleMicrobial Sensitivity TestsMothsSepsisAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemscarbapenem resistance genehypervirulentIncX3Klebsiella pneumoniaeST6417

Identifiers

PMID39162259
PMCPMC11448260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.